Recent News

• 05.28.2025 - Y-mAbs Virtual Radiopharmaceutical R&D Event
• 05.28.2025 - Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline
• 05.28.2025 - Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline
• 05.26.2025 - Y-mAbs Presents GD2-SADA PRIT Trial in Progress Poster at the Advances in Neuroblastoma Research Meeting
• 05.26.2025 - Y-mAbs Presents GD2-SADA PRIT Trial in Progress Poster at the Advances in Neuroblastoma Research Meeting
• 05.13.2025 - First Quarter 2025 Conference Call and Webcast
• 05.13.2025 - First Quarter 2025 Conference Call and Webcast
• 05.13.2025 - Y-mAbs to Host Virtual Radiopharmaceutical R&D Update on May 28, 2025
• 05.13.2025 - Y-mAbs to Host Virtual Radiopharmaceutical R&D Update on May 28, 2025
• 05.13.2025 - Y-mAbs Reports First Quarter 2025 Financial Results and Recent Corporate Developments

Recent Filings

• 05.28.2025 - EX-99.1 EX-99.1
• 05.28.2025 - 8-K Current report
• 05.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.13.2025 - 8-K Current report
• 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.13.2025 - EX-99.1 EX-99.1